Patents by Inventor Peter Kamp Busk

Peter Kamp Busk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9096895
    Abstract: The present invention relates to a method for amplification and quantification of microRNA molecules using quantitative reverse transcription polymerase chain reaction (qRT-PCR) technology. The method comprise the steps of (a) producing cDNA molecules complementary' to microRNAs in a sample using polyadenylation and primer extension by reverse transcription, and (b) amplification and quantification of the cDNAs by qPCR using microRNA specific primer sets of forward and reverse primers containing LNA monomers.
    Type: Grant
    Filed: February 2, 2010
    Date of Patent: August 4, 2015
    Assignee: EXIQON A/S
    Inventor: Peter Kamp Busk
  • Publication number: 20120071332
    Abstract: The present invention relates to a method for amplification and quantification of microRNA molecules using quantitative reverse transcription polymerase chain reaction (qRT-PCR) technology. The method comprise the steps of (a) producing cDNA molecules complementary to microRNAs in a sample using polyadenylation and primer extension by reverse transcription, and (b) amplification and quantification of the cDNAs by qPCR using microRNA specific primer sets of forward and reverse primers containing LNA monomers.
    Type: Application
    Filed: February 2, 2010
    Publication date: March 22, 2012
    Applicant: Exiqon A/S
    Inventor: Peter Kamp Busk
  • Publication number: 20030166202
    Abstract: The invention provides DNA coding for cytochrome P450 monooxygenases of the CYP79 family catalyzing the conversion of an aliphatic or aromatic amino acid or chain-elongated methionine homologue to the corresponding oxime. Preferred embodiments of the invention are enzymes catalyzing the conversion of L-Valine and L-Isoleucine such as the cassava enzymes CYP79D1 and CYP79D2, enzymes catalyzing the conversion of tyrosine such as the Triglochin maritima enzymes CYP79E1 and CYP79E2, enzymes catalyzing the conversion of tryptophan to the corresponding oxime indole-3-acetaldoxime such as the Arabidopsis thaliana enzyme CYP79A2 and the Brassica napus enzyme CYP79B5, and enzymes catalyzing the conversion of a chain-elongated methionine homologue such as the Arabidopsis thaliana enzymes CYP79F1 and CYP79F2. Transgenic expression of said DNA or parts thereof in plants can be used to manipulate the biosynthesis of corresponding glucosinolates or cyanogenic glucosides.
    Type: Application
    Filed: August 27, 2002
    Publication date: September 4, 2003
    Inventors: Mette Dahl Andersen, Birger Lindberg Moller, John Strikart Nielsen, Ute Wittstock, Carsten Horslev Hansen, Barbara Ann Halkier, Michael Dalgaard Mikkelsen, Peter Kamp Busk, Soren Bak